LMP2A、E-Cadherin和fibronectin在鼻咽癌中的表达及其临床意义

赵利容, 饶洁, 罗泊涛, 等. LMP2A、E-Cadherin和fibronectin在鼻咽癌中的表达及其临床意义[J]. 临床耳鼻咽喉头颈外科杂志, 2015, 29(2): 132-136. doi: 10.13201/j.issn.1001-1781.2015.02.010
引用本文: 赵利容, 饶洁, 罗泊涛, 等. LMP2A、E-Cadherin和fibronectin在鼻咽癌中的表达及其临床意义[J]. 临床耳鼻咽喉头颈外科杂志, 2015, 29(2): 132-136. doi: 10.13201/j.issn.1001-1781.2015.02.010
ZHAO Lirong, RAO Jie, LUO Botao, et al. Expression of LMP2A,E-Cadherin and fibronectin in nasopharyngeal carcinoma and its clinical significance[J]. J Clin Otorhinolaryngol Head Neck Surg, 2015, 29(2): 132-136. doi: 10.13201/j.issn.1001-1781.2015.02.010
Citation: ZHAO Lirong, RAO Jie, LUO Botao, et al. Expression of LMP2A,E-Cadherin and fibronectin in nasopharyngeal carcinoma and its clinical significance[J]. J Clin Otorhinolaryngol Head Neck Surg, 2015, 29(2): 132-136. doi: 10.13201/j.issn.1001-1781.2015.02.010

LMP2A、E-Cadherin和fibronectin在鼻咽癌中的表达及其临床意义

详细信息
    通讯作者: 罗泊涛;  陈小毅,E-mail:18924333954@189.cn
  • 中图分类号: R739.63

Expression of LMP2A,E-Cadherin and fibronectin in nasopharyngeal carcinoma and its clinical significance

More Information
    Corresponding authors: LUO Botao ;  CHEN Xiaoyi
  • 目的:探讨EBV编码的潜伏膜蛋白2A(LMP2A)与上皮-间质转化(EMT)标志物E-钙粘素(E-Cadherin)和纤维连接蛋白在鼻咽癌(NPC)中的表达及与临床病理学参数的关系。方法:采用免疫组织化学SP法检测LMP2A、E-Cadherin和fibronectin蛋白在32例鼻咽黏膜慢性炎、56例NPC和18例NPC淋巴结转移灶中的表达。结果:①LMP2A在NPC及其淋巴结转移灶中的阳性表达率分别为89.3%(50/56)和77.8%(14/18),均明显高于鼻咽黏膜慢性炎(37.5%,12/32)(均P<0.01);E-Cadherin在NPC及其淋巴结转移灶中的正常表达率分别为33.9%(19/56)和5.6%(1/18),均明显低于鼻咽黏膜慢性炎(90.6%,29/32)(均P<0.01);fibronectin在NPC及其淋巴结转移灶中的阳性表达率分别为83.9%(47/56)和72.2%(13/18),均明显高于鼻咽黏膜慢性炎(28.1%,9/32)(均P<0.01)。②NPC中LMP2A与E-Cadherin正常表达呈负相关(r=-0.387,P<0.01)、与fibronectin表达呈正相关(r=0.421,P<0.01)。③LMP2A、E-Cadherin和fibronectin表达与NPC患者N分期和临床分期密切相关(均P<0.05),与M分期无相关性(P>0.05);LMP2A、E-Cadherin表达与T分期也密切相关(均P<0.01)。结论:LMP2A、fibronectin在NPC中表达升高,而E-Cadherin正常表达则降低;LMP2A可能通过下调E-Cadherin和上调fibronectin表达来介导EMT促进NPC淋巴结转移和恶性进展。
  • 加载中
  • [1]

    MA B B, CHAN A T. Recent perspectives in the role of chemotherapy in the management of advanced nasopharyngeal carcinoma[J]. Cancer,2005,103:22-31.

    [2]

    THIERY J P, SLEEMAN J P. Complex networks orchestrate epithelial-mesenchymal transitions[J].Nat Rev Mol Cell Biol, 2006, 7:131-142.

    [3]

    LEE J M, DEDHAR S, KALLURI R, et al. The epithelial-mesenchymal transition:new insights in signaling, development, and disease[J]. J Cell Biol, 2006, 172:973-981.

    [4]

    NAKAYA T, KIKUCHI Y, KUNITA A, et al. Enrichment of stem-like cell population comprises transformation ability of Epstein-Barr virus latent membrane protein 2A for non-transformed cells[J]. Virus Res, 2013, 174:108-115.

    [5]

    赵水喜,王迎选,崔书祥,等.442例鼻咽癌放射治疗疗效观察[J].中国肿瘤临床, 2004, 31(10):595-596.

    [6]

    PACKEISEN J, KORSCHING E, HERBST H, et al. Demystified tissue microarray technology[J].Mol Pathol, 2003, 56:198-204.

    [7]

    SILER C A, RAAB-TRAUB N. Rhesus lymphocryptovirus latent membrane protein 2A activates beta-catenin signaling and inhibits differentiation in epithelial cells[J]. Virology, 2008, 377:273-279.

    [8]

    CHEN J. Roles of the PI3K/Akt pathway in Epstein-Barr virus-induced cancers and therapeutic implications[J]. World J Virol, 2012,1:154-161.

    [9]

    LAN Y Y, HSIAO J R, CHANG K C, et al. Epstein-Barr virus latent membrane protein 2A promotes invasion of nasopharyngeal carcinoma cells through ERK/Fra-1-mediated induction of matrix metalloproteinase 9[J]. J Virol, 2012, 86:6656- 6667.

    [10]

    PANOUSIS C G, ROWE D T. Epstein-Barr virus latent membrane protein 2 associates with and is a substrate for mitogen-activated protein kinase[J].J Virol, 1997, 71:4752-4760.

    [11]

    STEWART S, DAWSON C W, TAKADA K, et al. Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappaB transcription factor pathway[J].Proc Natl Acad Sci U S A, 2004,101:15730-15735.

    [12]

    PORT R J, PINHEIRO-MAIA S, HU C, et al. Epstein-Barr virus induction of the Hedgehog signalling pathway imposes a stem cell phenotype on human epithelial cells[J].J Pathol, 2013, 231:367-377.

    [13]

    徐洁洁,姚堃,俞晨杰,等. EB病毒LMP2A在鼻咽癌患者肿瘤组织中的表达及意义[J]. 临床耳鼻咽喉科杂志, 2005,19(11):484-487.

    [14]

    GUO D, XU B L, ZHANG X H, et al. Cancer stem-like side population cells in the human nasopharyngeal carcinoma cell line cne-2 possess epithelial mesenchymal transition properties in association with metastasis[J].Oncol Rep, 2012, 28:241-247.

    [15]

    THIERY J P.Epithelial-mesenchymal transitions in development and pathologies[J].Curr Opin Cell Biol, 2003, 15:740-746.

    [16]

    FRIXEN U H, BEHRENS J, SACHS M, et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells[J].J Cell Biol, 1991, 113:173-185.

    [17]

    LI Z, LIN S X,LIANG H Z.上皮型钙粘素与β-链接素在鼻咽原发癌及其淋巴结转移中的表达差异[J].中德临床肿瘤学杂志(英文版), 2004, 3(3):156-160.

    [18]

    TAKEYAMA H, MANOME Y, FUJIOKA K, et al. An extracellular matrix molecule, secreted by the epithelial-mesenchymal transition is associated with lymph Node metastasis of thyroid papillary carcinoma[J].Int J Endocrinol Metab. 2014, 12:e10748.

    [19]

    MA L J, LEE S W, LIN L C, et al. Fibronectin overexpression is associated with latent membrane protein 1 expression and has independent prognostic value for nasopharyngeal carcinoma[J].Tumour Biol, 2014, 35:1703-1712.

    [20]

    KONG Q L, HU L J, CAO J Y,et al.Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchy-mal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma[J]. PLoS Pathol, 2010, 6:e1000940.

  • 加载中
计量
  • 文章访问数:  41
  • PDF下载数:  30
  • 施引文献:  0
出版历程
收稿日期:  2014-04-08

目录